Found 12 hits of Enzyme Inhibition Constant Data Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287288
((S)-2-{(S)-2-[4-(4-Carbamimidoyl-phenoxy)-butyryla...)Show SMILES CCCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCOc1ccc(cc1)C(N)=N)C(O)=O Show InChI InChI=1S/C21H30N4O7/c1-2-3-5-15(21(30)31)25-20(29)16(12-18(27)28)24-17(26)6-4-11-32-14-9-7-13(8-10-14)19(22)23/h7-10,15-16H,2-6,11-12H2,1H3,(H3,22,23)(H,24,26)(H,25,29)(H,27,28)(H,30,31)/t15-,16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 76 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of binding to fibrinogen receptor |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50092111
((S)-2-{(S)-2-[4-(4-Carbamimidoyl-phenoxy)-butyryla...)Show SMILES CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCOc1ccc(cc1)C(N)=N)C(O)=O Show InChI InChI=1S/C20H28N4O7/c1-11(2)17(20(29)30)24-19(28)14(10-16(26)27)23-15(25)4-3-9-31-13-7-5-12(6-8-13)18(21)22/h5-8,11,14,17H,3-4,9-10H2,1-2H3,(H3,21,22)(H,23,25)(H,24,28)(H,26,27)(H,29,30)/t14-,17-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287287
((S)-3-[4-(4-Carbamimidoyl-phenoxy)-butyrylamino]-N...)Show SMILES CN([C@@H](Cc1ccc(O)cc1)C(O)=O)C(=O)[C@H](CC(O)=O)NC(=O)CCCOc1ccc(cc1)C(N)=N Show InChI InChI=1S/C25H30N4O8/c1-29(20(25(35)36)13-15-4-8-17(30)9-5-15)24(34)19(14-22(32)33)28-21(31)3-2-12-37-18-10-6-16(7-11-18)23(26)27/h4-11,19-20,30H,2-3,12-14H2,1H3,(H3,26,27)(H,28,31)(H,32,33)(H,35,36)/t19-,20-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 129 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287286
((S)-2-{(S)-2-[4-(4-Carbamimidoyl-phenoxy)-butyryla...)Show SMILES CC(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCOc1ccc(cc1)C(N)=N)C(O)=O Show InChI InChI=1S/C21H30N4O7/c1-12(2)10-16(21(30)31)25-20(29)15(11-18(27)28)24-17(26)4-3-9-32-14-7-5-13(6-8-14)19(22)23/h5-8,12,15-16H,3-4,9-11H2,1-2H3,(H3,22,23)(H,24,26)(H,25,29)(H,27,28)(H,30,31)/t15-,16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 135 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50421378
(CHEMBL146281)Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCOc1ccc(cc1)C(N)=N)C(O)=O Show InChI InChI=1S/C21H30N4O7/c1-3-12(2)18(21(30)31)25-20(29)15(11-17(27)28)24-16(26)5-4-10-32-14-8-6-13(7-9-14)19(22)23/h6-9,12,15,18H,3-5,10-11H2,1-2H3,(H3,22,23)(H,24,26)(H,25,29)(H,27,28)(H,30,31)/t12-,15-,18-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 141 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287282
((S)-3-[4-(4-Carbamimidoyl-phenoxy)-butyrylamino]-N...)Show SMILES NC(=N)c1ccc(OCCCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(O)=O)cc1 Show InChI InChI=1S/C24H28N4O8/c25-22(26)15-5-9-17(10-6-15)36-11-1-2-20(30)27-18(13-21(31)32)23(33)28-19(24(34)35)12-14-3-7-16(29)8-4-14/h3-10,18-19,29H,1-2,11-13H2,(H3,25,26)(H,27,30)(H,28,33)(H,31,32)(H,34,35)/t18-,19-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 158 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50422181
(CHEMBL146470)Show SMILES CC(C)(C)C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCOc1ccc(cc1)C(N)=N)C(O)=O Show InChI InChI=1S/C22H32N4O7/c1-22(2,3)12-16(21(31)32)26-20(30)15(11-18(28)29)25-17(27)5-4-10-33-14-8-6-13(7-9-14)19(23)24/h6-9,15-16H,4-5,10-12H2,1-3H3,(H3,23,24)(H,25,27)(H,26,30)(H,28,29)(H,31,32)/t15-,16-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 229 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287279
((S)-2-{(S)-2-[5-(4-Carbamimidoyl-phenoxy)-pentanoy...)Show SMILES CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)CCCCOc1ccc(cc1)C(N)=N)C(O)=O Show InChI InChI=1S/C21H30N4O7/c1-12(2)18(21(30)31)25-20(29)15(11-17(27)28)24-16(26)5-3-4-10-32-14-8-6-13(7-9-14)19(22)23/h6-9,12,15,18H,3-5,10-11H2,1-2H3,(H3,22,23)(H,24,26)(H,25,29)(H,27,28)(H,30,31)/t15-,18-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 229 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287281
((S)-3-[5-(4-Carbamimidoyl-phenoxy)-pentanoylamino]...)Show SMILES CN([C@@H](Cc1ccc(O)cc1)C(O)=O)C(=O)[C@H](CC(O)=O)NC(=O)CCCCOc1ccc(cc1)C(N)=N Show InChI InChI=1S/C26H32N4O8/c1-30(21(26(36)37)14-16-5-9-18(31)10-6-16)25(35)20(15-23(33)34)29-22(32)4-2-3-13-38-19-11-7-17(8-12-19)24(27)28/h5-12,20-21,31H,2-4,13-15H2,1H3,(H3,27,28)(H,29,32)(H,33,34)(H,36,37)/t20-,21-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 269 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287278
((S)-3-[5-(4-Carbamimidoyl-phenoxy)-pentanoylamino]...)Show SMILES NC(=N)c1ccc(OCCCCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](Cc2ccc(O)cc2)C(O)=O)cc1 Show InChI InChI=1S/C25H30N4O8/c26-23(27)16-6-10-18(11-7-16)37-12-2-1-3-21(31)28-19(14-22(32)33)24(34)29-20(25(35)36)13-15-4-8-17(30)9-5-15/h4-11,19-20,30H,1-3,12-14H2,(H3,26,27)(H,28,31)(H,29,34)(H,32,33)(H,35,36)/t19-,20-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 646 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50422180
(CHEMBL145961)Show SMILES COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(O)=O)NC(=O)CCCCOc1ccc(cc1)C(N)=N Show InChI InChI=1S/C26H32N4O8/c1-37-26(36)21(14-16-5-9-18(31)10-6-16)30-25(35)20(15-23(33)34)29-22(32)4-2-3-13-38-19-11-7-17(8-12-19)24(27)28/h5-12,20-21,31H,2-4,13-15H2,1H3,(H3,27,28)(H,29,32)(H,30,35)(H,33,34)/t20-,21-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 4.47E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of binding to integrin alphaIIb-beta3 |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Integrin alpha-IIb/beta-3
(Homo sapiens (Human)) | BDBM50287285
((S)-3-[5-(4-Carbamimidoyl-phenoxy)-pentanoylamino]...)Show SMILES NC(=N)c1ccc(OCCCCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O)cc1 Show InChI InChI=1S/C19H26N4O8/c20-17(21)11-4-6-12(7-5-11)31-8-2-1-3-15(25)22-13(9-16(26)27)18(28)23-14(10-24)19(29)30/h4-7,13-14,24H,1-3,8-10H2,(H3,20,21)(H,22,25)(H,23,28)(H,26,27)(H,29,30)/t13-,14-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 1.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Company Ltd.
Curated by ChEMBL
| Assay Description
Inhibition of alphaIIb-beta3 integrin |
J Med Chem 39: 5017-20 (1997)
Article DOI: 10.1021/jm960557i
BindingDB Entry DOI: 10.7270/Q2T72JQ8 |
More data for this
Ligand-Target Pair | |
Search and Browse
